000 | 02924nam a22004097a 4500 | ||
---|---|---|---|
008 | 230411s20232023 xxu||||| |||| 00| 0 eng d | ||
022 | _a0271-678X | ||
024 | _a10.1177/0271678X231155222 [doi] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a36748316 | ||
245 | _aPost-ischemic hyperemia following endovascular therapy for acute stroke is associated with lesion growth. | ||
251 | _aJournal of Cerebral Blood Flow & Metabolism. :271678X231155222, 2023 Feb 07 | ||
252 | _aJ Cereb Blood Flow Metab. :271678X231155222, 2023 Feb 07 | ||
253 | _aJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism | ||
260 | _c2023 | ||
260 | _fFY2023 | ||
260 | _p2023 Feb 07 | ||
265 | _saheadofprint | ||
265 | _tPublisher | ||
266 | _d2023-04-11 | ||
520 | _aA substantial proportion of acute stroke patients fail to recover following successful endovascular therapy (EVT) and injury to the brain and vasculature secondary to reperfusion may be a contributor. Acute stroke patients were included with: i) large vessel occlusion of the anterior circulation, ii) successful recanalization, and iii) evaluable MRI early after EVT. Presence of hyperemia on MRI perfusion was assessed by consensus using a modified ASPECTS. Three different approaches were used to quantify relative cerebral blood flow (rCBF). Sixty-seven patients with median age of 66 [59-76], 57% female, met inclusion criteria. Hyperemia was present in 35/67 (52%) patients early post-EVT, in 32/65 (49%) patients at 24 hours, and in 19/48 (40%) patients at 5 days. There were no differences in incomplete reperfusion, HT, PH-2, HARM, severe HARM or symptomatic ICH rates between those with and without early post-EVT hyperemia. A strong association (R2 = 0.81, p < 0.001) was found between early post-EVT hyperemia (p = 0.027) and DWI volume at 24 hours after adjusting for DWI volume at 2 hours (p < 0.001) and incomplete reperfusion at 24 hours (p = 0.001). Early hyperemia is a potential marker for cerebrovascular injury and may help select patients for adjunctive therapy to prevent edema, reperfusion injury, and lesion growth. | ||
546 | _aEnglish | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aNeurology | ||
656 | _aNursing | ||
657 | _aJournal Article | ||
700 |
_aBurton, Shannon _bMWHC |
||
700 | _aCabatbat, Rainier | ||
700 |
_aCraft, Veronica _bMWHC |
||
700 |
_aHsia, Amie W _bMWHC |
||
700 |
_aKim, Yongwoo _bMWHC |
||
700 |
_aUche, Victoria _bMWHC |
||
790 | _aLuby M, Hsia AW, Lomahan CA, Davis R, Burton S, Kim Y, Craft V, Uche V, Cabatbat R, Adil MM, Thomas LC, De Vis JB, Afzal MM, McGavern D, Lynch JK, Leigh R, Latour LL | ||
856 |
_uhttps://dx.doi.org/10.1177/0271678X231155222 _zhttps://dx.doi.org/10.1177/0271678X231155222 |
||
942 |
_cART _dArticle |
||
999 |
_c11643 _d11643 |